• Home

  • HEALTH CARE

  • HEALTHY LIFESTYLE

  • HYGIENE

  • COSMETICS

  • FOR HIM

  • PREGNANCY AND MOTHERHOOD

  • CHILD

    2. HEALTH CARE
    3. Diemono 2mg 28 tablets — Made in Germany — Free Delivery

    Diemono 2mg 28 tablets — Made in Germany — Free Delivery


    Brand: Mibe GmbH
    Product Code: Diemono
    Availability: In Stock
    $43.66
    Add to Cart

    Product description 

    Diemono are hormones of the gonads and preparations used in the pathology of the genital organs. Progestogens. Derivatives of pregnadiene. Indications for use - treatment of endometriosis.

    Compound

    1 tablet contains 2 mg dienogest;
    excipients: lactose, corn starch, maltodextrin, magnesium stearate, hypromellose 15 cf, titanium dioxide (E 171), macrogol 4000, sodium.

    Contraindications

    Diemono® should not be used in the presence of any of the following conditions or diseases. If any of these conditions or diseases occur while using Diemono®, the preparation should be stopped immediately:
    • hypersensitivity to the active substance or to any excipients that make up the preparation;
    • venous thromboembolism in an active form;
    • history of arterial or cardiovascular diseases (for example, myocardial infarction, stroke, coronary heart disease);
    • diabetes mellitus with vascular damage;
    • a history of severe liver disease, while liver function tests are not normal;
    • history of liver tumors (benign or malignant)
    • known or suspected malignant tumors dependent on sex hormones;
    • vaginal bleeding of unknown etiology.

    Mode of application

    Take 1 tablet daily without interruption in taking the preparation at approximately the same time with a small amount of liquid. The tablets can be taken with or without food.
    The tablets should be taken regularly, regardless of vaginal bleeding. As soon as the tablets from one package are over, start taking the tablets from the next package without interrupting the use of the preparation.
    There is no experience of treating Diemono® in patients with endometriosis longer than 15 months.
    You can start taking the preparation on any day of the menstrual cycle.

    Application features

    Since Diemono® contains only progestogen, it is believed that special precautions and safety measures when using preparations containing only progestogen also apply to Diemono®.
    In the event of the presence or exacerbation of any of the following conditions / risk factors, an individual analysis of the risk-benefit ratio should be carried out before starting or continuing therapy with Diemono®.
    Severe uterine bleeding
    Uterine bleeding, for example, in women with uterine adenomyosis or uterine leiomyoma may increase with the use of Diemono®. If the bleeding is severe and does not stop for a long time, it can lead to anemia (in some cases severe). If anemia develops, consideration should be given to discontinuing Diemono®.
    Change in the nature of bleeding
    In most patients, when taking dienogest 2 mg, a change in the nature of menstrual bleeding occurs.
    pregnant
    There are limited data on the use of dienogest in pregnant women.
    Animal studies do not indicate direct or indirect adverse effects in terms of reproductive toxicity.
    Children
    Diemono® is not indicated for children and adolescents before menarche.
    Drivers
    No effect on the ability to drive vehicles or work with other mechanisms was observed in patients taking preparations containing dienogest.

    Overdose

    The study of acute toxicity of dienogest does not indicate the risk of developing acute adverse reactions in case of unintentional intake of several daily therapeutic doses. There is no specific antidote. The use of dienogest at a dose of 20-30 mg per day (which is 10-15 times higher than the dose in Diemono®) for more than 24 weeks was very well tolerated.

    Side effects

    Adverse reactions are described according to MedDRA. The most appropriate MedDRA term has been applied to describe the specific reaction and associated conditions.
    Adverse reactions most often develop during the first months after the start of the use of Diemono® and disappear with continued treatment. There may be changes in the pattern of menstrual bleeding, such as spotting, irregular bleeding, or amenorrhea. The following adverse reactions have been reported in patients treated with dienogest 2 mg.

    Storage conditions

    No special storage conditions required. Keep out of the reach of children.

    There are no reviews for this product.
    VEV Healthcare Store © 2017